Epilepsy

Classification of ethiology could divided in four categories:

• idiopathic epilepsy
• symptomatic epilepsy
• provoked epilepsy
• cryptogenic epilepsy

It is difficult to distinguish between genetic and cryptogenic syndromes.

Morbility data is difficult to interpret when WHO states 50-70 millions persons suffers epilepsy

nonadherence appears to be associated with increased health care costs, nevertheless XR-medicine appears as strategy to overcome compliance with AED

eslicarbazepine

riluzole

sulthiame

A review of the efficacy and safety of eslicarbazepine acetate in the management of partial-onset seizures

Eslicarbazepine acetate for the treatment of focal epilepsy:an update on its proposed mechanisms of action

In vitro transport profile of carbamazepine, oxcarbazepine, eslicarbazepine acetate, and their active metabolites by human P-glycoprotein

Diverse Mechanisms of Antiepileptic Drugs in the Development Pipeline

ILAE Classification

ILAE Overview

See also

A new perspective for Epileptic Disorders

Links

  Interwiki via Wikidata

Epilepsies: diagnosis and management clinical guide

Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population

The Efficacy of Leviteracetam versus Carbamazepine for Epilepsy: A Meta-Analysis

The intrinsic severity hypothesis of pharmacoresistance to antiepileptic drugs

Models of epilepsy

purinergic signalling:therapeutic developments

Electroencephalography in the Diagnosis of Genetic Generalized Epilepsy Syndromes

Ranking the Leading Risk Factors for Sudden Unexpected Death in Epilepsy

Lennox-Gastaut Syndrome

BECTS

Dravet's syndrome

Status epilepticus

Panayiotopoulos syndrome

epilepsia partialis continua

West's syndrome

Ohtahara syndrome

Pretzel syndrome

Doose syndrome

References

References: